Breaking
Argentina's Paredes banned for 10 games after World Cup final clashes Cleanup underway after tornadoes touch down in Delaware and New York’s Long Island Laken Snelling, ex-Kentucky student whose infant was found dead in closet, pleads guilty to manslaughter Eye drops recalled over possible contamination, FDA reports Jannik Sinner ‘very sad and disappointed’ as knee injury puts him out of US Open Smoke and mirrors fill the vacuum as Springboks and All Blacks brace for battle ‘We’re barely above porn’: why would a film-maker choose to make a deliberately bad ‘mockbuster’? Medalist Simpson to stop running after collapse Partey signs for Al-Shabab in Saudi Pro League Tour of Britain Women: Kim Le Court storms to stage three win and overall lead
NEWSREEL
The day, in 30-second reels.
--:--:--
World / Reel
World · Video brief

Eye drops recalled over possible contamination, FDA reports

A popular eye drop brand, Clear Eyes Maximum Itchy Eye Relief, is under recall due to contamination concerns. The FDA has classified this as Class II, affecting over 39,000 bottles sold nationwide. Consumers should check for Lot 2552A produ...

NBC News· Aug 21, 2026 · 4:36 PM · 1 views

Video won't play? Watch on YouTube →

A popular eye drop brand, Clear Eyes Maximum Itchy Eye Relief, is under recall due to contamination concerns. The FDA has classified this as Class II, affecting over 39,000 bottles sold nationwide. Consumers should check for Lot 2552A products expiring on September 30, 2027.

Full story and more reels: https://newsreel.video #news #breaking #FDA #recall #health #eyecare #contamination #ClearEyes

Originally reported by NBC News. Read the full story →

More in World

World World
World

Cleanup underway after tornadoes touch down in Delaware and New York’s Long Island

AP News· 10 minutes ago
World World
World

Jannik Sinner ‘very sad and disappointed’ as knee injury puts him out of US Open

The Guardian· 10 minutes ago
World World
World

Trump and former fixer Michael Cohen bury the hatchet

NBC News· 2 hours ago

0 Comments

No comments yet. Be the first.